摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

retinyl N,N-diethyl-2-aminoacetate | 1040750-85-3

中文名称
——
中文别名
——
英文名称
retinyl N,N-diethyl-2-aminoacetate
英文别名
retinyl N,N-diethyl-2-aminoacetate hydrochloride;retinyl N,N-dimethyl-2-aminoacetate hydrochloride;[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] 2-(dimethylamino)acetate;hydrochloride
retinyl N,N-diethyl-2-aminoacetate化学式
CAS
1040750-85-3
化学式
C24H37NO2*ClH
mdl
——
分子量
408.024
InChiKey
YFUYLQYZJCQUKH-YHCQPEIKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.04
  • 重原子数:
    28
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    二甲基氨基氯化氢维生素A三乙胺 作用下, 以 乙腈 为溶剂, 反应 5.0h, 以75.5%的产率得到retinyl N,N-diethyl-2-aminoacetate
    参考文献:
    名称:
    非常に高い皮膚浸透率を有するレチノイド及びレチノイド様化合物の正に荷電した水溶性プロドラッグ
    摘要:
    设计和合成一种新的带正电荷的構造31型维生素A酸或类维生素A酸类似化合物的前药。这些带正电荷的前药的氨基不仅显著增加了药物在水中的溶解性,而且能够与膜的磷酸基部位的负电荷结合。这种结合会轻微干扰膜,并为前药的疏水部分提供空间。当膜分子移动时,为了前药的结合,膜会略微“裂开”,从而使前药插入膜中。前药可在人类或动物中医药上用于治疗处于治疗可能状态的维生素A酸或类维生素A酸类似化合物。前药可经皮途径用于任何类型的医疗治疗,并且可以避免绝大部分维生素A酸或类维生素A酸类似化合物的副作用。【选定图】图2
    公开号:
    JP2017160261A
点击查看最新优质反应信息

文献信息

  • HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS
    申请人:Yu Chongxi
    公开号:US20100010084A1
    公开(公告)日:2010-01-14
    The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of retinoids and retinoid-related compounds, which are capable of crossing biological barriers with high penetration efficiency. The HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.
    本发明提供了一种新型高穿透力(retinoids)和相关化合物的高穿透力前药(HPP)或高穿透力制剂(HPC)的组合物,能够高效地穿过生物屏障。HPP能够在穿过生物屏障后转化为原活性药物或药物代谢物,从而可以治疗与原药物或代谢物相关的疾病。此外,HPP能够到达原药物无法进入或无法在目标区域达到足够浓度的区域,从而提供新的治疗方法。HPP可以通过各种给药途径给予受试者,例如在治疗区域局部给药以高浓度作用或全身给药以更快的速率进入循环系统。
  • WO2008/87493
    申请人:——
    公开号:——
    公开(公告)日:——
  • POSITIVELY CHARGED WATER-SOLUBLE PRODRUGS OF RETINOIDS AND RETINOID-LIKE COMPOUNDS WITH VERY HIGH SKIN PENETRATION RATES
    申请人:Yu, Chongxi
    公开号:EP2125697B1
    公开(公告)日:2016-09-28
  • HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
    申请人:Yu Chongxi
    公开号:US20110269689A1
    公开(公告)日:2011-11-03
    High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent drugs or parent drug-related compounds such as metabolites after crossing one or more biological barriers and thus can render treatments for the conditions that the parent drugs or parent drug-related compounds can. Additionally, the HPCs are capable of reaching areas that their parent drugs or parent drug-related compounds may not be able to access or to render a sufficient concentration at the target areas HPCs of NSAIA, for example, have demonstrated indications such as treating hair loss. A HPC can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.
  • HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOIDS-RELATED COMPOUNDS
    申请人:Techfields Pharma Co., Ltd.
    公开号:US20210196664A1
    公开(公告)日:2021-07-01
    The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of retinoids and retinoid-related compounds, which are capable of crossing biological barriers with high penetration efficiency. The HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.
查看更多

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸 黄黄质 黄钟花醌 黄质醛 黄褐毛忍冬皂苷A 黄蝉花素 黄蝉花定